These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10321632)

  • 1. Severe nonendemic pemphigus foliaceus presenting in the postpartum period.
    Nousari HC; Kimyai-Asadi A; Ketabchi N; Diaz LA; Anhalt GJ
    J Am Acad Dermatol; 1999 May; 40(5 Pt 2):845-6. PubMed ID: 10321632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analyses of autoantigens in a new form of endemic pemphigus foliaceus in Colombia.
    Abrèu-Velez AM; Beutner EH; Montoya F; Bollag WB; Hashimoto T
    J Am Acad Dermatol; 2003 Oct; 49(4):609-14. PubMed ID: 14512904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection against pemphigus foliaceus by desmoglein 3 in neonates.
    Wu H; Wang ZH; Yan A; Lyle S; Fakharzadeh S; Wahl JK; Wheelock MJ; Ishikawa H; Uitto J; Amagai M; Stanley JR
    N Engl J Med; 2000 Jul; 343(1):31-5. PubMed ID: 10882766
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunopathological diagnosis of pemphigus foliaceus.
    Jarzabek-Chorzelska M; Jablonska S; Kolacinska-Strasz Z; Sulej I
    Dermatology; 2002; 205(4):413-5; author reply 415-6; discussion 416. PubMed ID: 12444343
    [No Abstract]   [Full Text] [Related]  

  • 5. Pemphigus herpetiformis is a rare clinical expression of nonendemic pemphigus foliaceus, fogo selvagem, and pemphigus vulgaris. Cooperative Group on Fogo Selvagem Research.
    Santi CG; Maruta CW; Aoki V; Sotto MN; Rivitti EA; Diaz LA
    J Am Acad Dermatol; 1996 Jan; 34(1):40-6. PubMed ID: 8543693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pemphigus Herpetiformis With Autoantibodies to Desmoglein 1 and 3.
    Galvañ-Pérez Del Pulgar JI; Tercedor-Sánchez J; Jiménez-Gallo D; Linares-Barrios M
    Actas Dermosifiliogr; 2016 Nov; 107(9):785-786. PubMed ID: 27340117
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chronic lymphocytic leukemia revealed by atypic pemphigus].
    Voisard J; Beylot-Barry M; Doutre M; Vergier B; Marrot F; Joly P; Beylot C
    Ann Dermatol Venereol; 2000 May; 127(5):492-5. PubMed ID: 10863179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ELISA testing of anti-desmoglein 1 and 3 antibodies in the management of pemphigus.
    Abasq C; Mouquet H; Gilbert D; Tron F; Grassi V; Musette P; Joly P
    Arch Dermatol; 2009 May; 145(5):529-35. PubMed ID: 19451496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical IgA/IgG pemphigus involving the skin, oral mucosa, and colon in a child: a novel variant of IgA pemphigus?
    Bruckner AL; Fitzpatrick JE; Hashimoto T; Weston WL; Morelli JG
    Pediatr Dermatol; 2005; 22(4):321-7. PubMed ID: 16060868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pemphigus foliaceus with prominent neutrophilic pustules.
    Matsuo K; Komai A; Ishii K; Futei Y; Amagai M; Deguchi H; Danno K; Hashimoto T
    Br J Dermatol; 2001 Jul; 145(1):132-6. PubMed ID: 11453922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three cases of transition from pemphigus vulgaris to pemphigus foliaceus confirmed by desmoglein ELISA.
    Ng PP; Thng ST
    Dermatology; 2005; 210(4):319-21. PubMed ID: 15942219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anti-desmoglein 1 autoantibodies in pemphigus vulgaris sera are pathogenic.
    Ding X; Diaz LA; Fairley JA; Giudice GJ; Liu Z
    J Invest Dermatol; 1999 May; 112(5):739-43. PubMed ID: 10233765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Localized pemphigus].
    Kharfi M; Fazaa B; Benmously R; Bouden S; Elloumi L; Kamoun MR
    Ann Dermatol Venereol; 2003; 130(6-7):645-7. PubMed ID: 13679705
    [No Abstract]   [Full Text] [Related]  

  • 14. Shift in clinical features, histologic findings and antigen profiles from pemphigus vulgaris to pemphigus foliaceus--two case studies.
    Kawana S; Hashimoto T; Nishikawa T; Nishiyama S
    Dermatology; 1994; 189 Suppl 1():57-9. PubMed ID: 8049565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Juvenile pemphigus foliaceus.
    Mehravaran M; Morvay M; Molnár K; Oláh J; Korom I; Husz S; Dobozy A
    Br J Dermatol; 1998 Sep; 139(3):496-9. PubMed ID: 9767298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous pemphigus vulgaris with absence of desmoglein 1 autoantibodies. An example of the extended desmoglein compensation theory.
    Carew B; Wagner G
    Australas J Dermatol; 2014 Nov; 55(4):292-5. PubMed ID: 25399788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aggressive immunosuppressive therapy for a refractory case of IgA pemphigus.
    Sibley Hash K; Rencic A; Hernandez MI; Hashimoto T; Nousari HC
    Arch Dermatol; 2002 Jun; 138(6):744-6. PubMed ID: 12056953
    [No Abstract]   [Full Text] [Related]  

  • 18. [Transition from pemphigus vulgaris to pemphigus foliaceus: a case report].
    Lévy-Sitbon C; Reguiaï Z; Durlach A; Goeldel AL; Grange F; Bernard P
    Ann Dermatol Venereol; 2013 Dec; 140(12):788-92. PubMed ID: 24315225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoablative high-dose cyclophosphamide without stem cell rescue in pemphigus foliaceus.
    Cohen MA; Cohen JJ; Kerdel FA
    Int J Dermatol; 2002 Jun; 41(6):340-4. PubMed ID: 12100688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgA pemphigus--occurrence of anti-desmocollin 1 and anti-desmoglein 1 antibody reactivity in an individual patient.
    Kopp T; Sitaru C; Pieczkowski F; Schneeberger A; Födinger D; Zillikens D; Stingl G; Karlhofer FM
    J Dtsch Dermatol Ges; 2006 Dec; 4(12):1045-50. PubMed ID: 17176412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.